In the development and progression of pancreatic cancer, miR-30 c had vital functions by targeting twinfilin 1 (TWF1) [28] or DNA topoisomerase II alpha gene (TOP2A) [29]. The gene discussed is TOP2A; the disease is pancreatic neoplasm.